Clinical relevance of IDH1/2 mutant allele burden during follow-up in acute myeloid leukemia. A study by the French ALFA group

Assessment of minimal residual disease has emerged as a powerful prognostic factor in acute myeloid leukemia. In this study, we investigated the potential of IDH1/2 mutations as targets for minimal residual disease assessment in acute myeloid leukemia, since these mutations collectively occur in 15–...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Yann Ferret, Nicolas Boissel, Nathalie Helevaut, Jordan Madic, Olivier Nibourel, Alice Marceau-Renaut, Maxime Bucci, Sandrine Geffroy, Karine Celli-Lebras, Sylvie Castaigne, Xavier Thomas, Christine Terré, Hervé Dombret, Claude Preudhomme, Aline Renneville
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Ferrata Storti Foundation 2018-05-01
Colecção:	Haematologica
Acesso em linha:	https://haematologica.org/article/view/8452
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!